VanEck ChiNext ETF (CNXT)
| Assets | $14.58M |
| Expense Ratio | 0.65% |
| PE Ratio | 22.98 |
| Shares Out | 650,000 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Ratio | n/a |
| 1-Year Return | -24.83% |
| Volume | 1,426 |
| Open | 22.34 |
| Previous Close | 22.37 |
| Day's Range | 22.34 - 22.43 |
| 52-Week Low | 19.65 |
| 52-Week High | 31.00 |
| Beta | 0.50 |
| Holdings | 101 |
| Inception Date | Jul 23, 2014 |
About CNXT
Fund Home PageThe VanEck ChiNext ETF (CNXT) is an exchange-traded fund that is based on the ChiNext - RMB index. The fund tracks a cap-weighted index of 100 small- and medium-size companies traded on the SME Board and ChiNext Board of the Shenzhen Stock Exchange. CNXT was launched on Jul 23, 2014 and is issued by VanEck.
Top 10 Holdings
53.24% of assets| Name | Symbol | Weight |
|---|---|---|
| Contemporary Amperex Technology Co Ltd | 300750.SZ | 18.85% |
| East Money Information Co Ltd | 300059.SZ | 6.20% |
| Shenzhen Mindray Bio-Medical Electronic | 300760.SZ | 5.97% |
| Shenzhen Inovance Technology Co Ltd | 300124.SZ | 4.48% |
| Zhongji Innolight Co Ltd | 300308.SZ | 4.16% |
| Wens Foodstuffs Group Co Ltd | 300498.SZ | 4.12% |
| Sungrow Power Supply Co Ltd | 300274.SZ | 3.78% |
| Aier Eye Hospital Group Co Ltd | 300015.SZ | 2.03% |
| Eoptolink Technology Inc Ltd | 300502.SZ | 1.94% |
| Eve Energy Co Ltd | 300014.SZ | 1.71% |
News
Best China ETFs for Q2 2021
The best China ETFs for Q2 2021 are KGRN, CHIQ, and CNXT.
Chinese stocks have biggest gains in 3 months
Yahoo Finance's Tom Belger reports on the latest stock news from China and Europe.
Countries beating the coronavirus are getting 'rewarded' in the stock market, ETF analysts say
Some European and Chinese ETFs have been outperforming as the underlying countries get the coronavirus under control, analysts say.
Cannabis, China and cancer treatment: These are 2019's best performing ETFs
The top performing ETFs so far in 2019 hit on three major themes: China, cannabis and genomics. Bob Pisani breaks down the trend with CFRA's Todd Rosenbluth and Astoria Advisors' John Davi.